Stuart Bailey

Follow

Generating author description...

All published works
Action Title Year Authors
+ Incorporating historical information to improve phase I clinical trials 2021 Yanhong Zhou
J. Jack Lee
Shunguang Wang
Stuart Bailey
Ying Yuan
+ PDF Chat Machine learning for clinical trials in the era of COVID-19 2020 William R. Zame
Ioana Bica
Cong Shen
Alicia Curth
Hyun-Suk Lee
Stuart Bailey
James Weatherall
David Wright
Frank Bretz
Mihaela van der Schaar
+ Incorporating historical information to improve phase I clinical trial designs 2020 Yanhong Zhou
J.Jack Lee
Shunguang Wang
Stuart Bailey
Ying Yuan
+ Rendering the 3 + 3 Design to Rest: More Efficient Approaches to Oncology Dose-Finding Trials in the Era of Targeted Therapy 2016 Lei Nie
Eric H. Rubin
Nitin Mehrotra
José Cirı́aco Pinheiro
Laura L. Fernandes
Amit Roy
Stuart Bailey
Dinesh P. de Alwis
+ Robust exchangeability designs for early phase clinical trials with multiple strata 2015 Beat Neuenschwander
Simon Wandel
Satrajit Roychoudhury
Stuart Bailey
+ PDF Chat Advancing Clinical Trials to Streamline Drug Development 2015 Susan E. Bates
Donald A. Berry
Sanjeeve Balasubramaniam
Stuart Bailey
Patricia LoRusso
Eric H. Rubin
+ 858 Bayesian Adaptive Dose-escalation Designs in Practice 2012 Simon Wandel
Beat Neuenschwander
Stuart Bailey
+ Bayesian model-based approaches for single and combination dose finding 2011 Stuart Bailey
+ Bayesian Dose Finding in Oncology for Drug Combinations by Copula Regression 2010 Mauro Gasparini
Stuart Bailey
Beat Neuenschwander
+ A Bayesian Case Study in Oncology Phase I Combination Dose-Finding Using Logistic Regression with Covariates 2009 Stuart Bailey
Beat Neuenschwander
Glen Laird
Michael Branson
Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ PDF Chat Critical aspects of the Bayesian approach to phase I cancer trials 2008 Beat Neuenschwander
Michael Branson
Thomas Gsponer
7
+ Cancer phase I clinical trials: efficient dose escalation with overdose control 1998 James S. Babb
André Rogatko
Shelemyahu Zacks
6
+ Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer 1990 John O’Quigley
Margaret S. Pepe
Lloyd D. Fisher
5
+ PDF Chat A modified toxicity probability interval method for dose-finding trials 2010 Yuan Ji
Ping Liu
Yisheng Li
B. Nebiyou Bekele
3
+ PDF Chat Translation of Innovative Designs Into Phase I Trials 2007 André Rogatko
David J. Schoeneck
William Jonas
Mourad Tighiouart
Fadlo R. Khuri
Alan L. Porter
3
+ Design and Analysis of Phase I Clinical Trials 1989 Barry E. Storer
3
+ A Bayesian Case Study in Oncology Phase I Combination Dose-Finding Using Logistic Regression with Covariates 2009 Stuart Bailey
Beat Neuenschwander
Glen Laird
Michael Branson
3
+ AN EXTENSION OF THE CONTINUAL REASSESSMENT METHODS USING A PRELIMINARY UP‐AND‐DOWN DESIGN IN A DOSE FINDING STUDY IN CANCER PATIENTS, IN ORDER TO INVESTIGATE A GREATER RANGE OF DOSES 1995 Susanne Møller
2
+ Some practical improvements in the continual reassessment method for phase I studies 1995 Steven N. Goodman
Marianna Zahurak
Steven Piantadosi
2
+ Accuracy, Safety, and Reliability of Novel Phase I Trial Designs 2018 Heng Zhou
Ying Yuan
Lei Nie
2
+ Statistical Methods in Drug Combination Studies 2014 Wei Zhao
Harry Yang
2
+ PDF Chat Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical Trials 2017 Fangrong Yan
Sumithra J. Mandrekar
Ying Yuan
2
+ PDF Chat Determining the Effective Sample Size of a Parametric Prior 2007 Satoshi Morita
Peter F. Thall
Peter Müller
2
+ PDF Chat Application of the continual reassessment method to a phase I dose‐finding trial in Japanese patients: East meets West 2011 Satoshi Morita
2
+ PA‐CRM: A continuous reassessment method for pediatric phase I oncology trials with concurrent adult trials 2020 Yimei Li
Ying Yuan
2
+ Robust meta‐analytic‐predictive priors in clinical trials with historical control information 2014 Heinz Schmidli
Sandro Gsteiger
Satrajit Roychoudhury
Anthony O’Hagan
David J. Spiegelhalter
Beat Neuenschwander
2
+ Bridging continual reassessment method for phase I clinical trials in different ethnic populations 2015 Suyu Liu
Haitao Pan
Jielai Xia
Qin Huang
Ying Yuan
2
+ Bayesian Approaches to Clinical Trials and Health‐Care Evaluation 2003 David J. Spiegelhalter
Keith R. Abrams
Jonathan P. Myles
2
+ PDF Chat Unified approach for extrapolation and bridging of adult information in early-phase dose-finding paediatric studies 2016 Caroline Petit
Adeline Samson
Satoshi Morita
Moreno Ursino
Jérémie Guedj
Vincent Jullien
Emmanuelle Comets
Sarah Zohar
2
+ Model-Assisted Designs for Early-Phase Clinical Trials: Simplicity Meets Superiority 2019 Ying Yuan
J. Jack Lee
Susan G. Hilsenbeck
2
+ PDF Chat Bayesian optimal interval designs for phase I clinical trials 2014 Suyu Liu
Ying Yuan
2
+ Dose‐Finding with Two Agents in Phase I Oncology Trials 2003 Peter F. Thall
Randall E. Millikan
Peter P. Mueller
Sang Joon Lee
2
+ Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials 2009 Guosheng Yin
Ying Yuan
2
+ An approach to meta‐analysis of dose‐finding studies 2011 Sarah Zohar
Sandrine Katsahian
John O’Quigley
2
+ PDF Chat Rethinking Risk-Benefit Assessment for Phase I Cancer Trials 2006 Steven Joffe
Franklin G. Miller
2
+ PDF Chat A Bayesian interval dose-finding design addressingOckham's razor: mTPI-2 2017 Wentian Guo
Sue‐Jane Wang
Shengjie Yang
Henry Lynn
Yuan Ji
2
+ Comparative review of novel model‐assisted designs for phase I clinical trials 2018 Heng Zhou
Thomas A. Murray
Haitao Pan
Ying Yuan
2
+ Bayesian models for subgroup analysis in clinical trials 2011 Hayley E. Jones
David Ohlssen
Beat Neuenschwander
Amy Racine
Michael Branson
1
+ PDF Chat Commensurate Priors for Incorporating Historical Information in Clinical Trials Using General and Generalized Linear Models 2012 Brian P. Hobbs
Daniel J. Sargent
Bradley P. Carlin
1
+ A Bayesian Approach to Jointly Modeling Toxicity and Biomarker Expression in a Phase I/II Dose‐Finding Trial 2005 B. Nebiyou Bekele
Yu Shen
1
+ Adaptive clinical trials in oncology 2011 Donald A. Berry
1
+ Model Selection: An Integral Part of Inference 1997 S. T. Buckland
Kenneth P. Burnham
Nicole H. Augustin
1
+ Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging Trials 2007 Björn Bornkamp
Frank Bretz
Alex Dmitrienko
Greg Enas
Brenda Gaydos
Chyi‐Hung Hsu
Franz König
Michael Krams
Qing Liu
Beat Neuenschwander
1
+ Optimizing Dosing of Oncology Drugs 2014 Lori M. Minasian
Osnat Rosen
Daniel Auclair
Atiqur Rahman
Richard Pazdur
Richard L. Schilsky
1
+ Empirical Bayes estimates of subgroup effects in clinical trials 1990 C.E. Davis
Diane P. Leffingwell
1
+ Testing a Point Null Hypothesis: The Irreconcilability of<i>P</i>Values and Evidence 1987 James O. Berger
Thomas Sellke
1
+ PDF Chat Power prior distributions for regression models 2000 Ming‐Hui Chen
Joseph G. Ibrahim
1
+ PDF Chat Borrowing Strength with Nonexchangeable Priors over Subpopulations 2011 Luis León‐Novelo
B. Nebiyou Bekele
P. Müller
Fernando A. Quintana
Kyle Wathen
1
+ TWO-SAMPLE CONTINUAL REASSESSMENT METHOD 1999 John O’Quigley
Larry Z. Shen
Anthony Gamst
1
+ Bayesian heavy-tailed models and conflict resolution: A review 2012 Anthony O’Hagan
Luis R. Pericchi
1
+ Time‐to‐event continual reassessment method incorporating treatment cycle information with application to an oncology phase I trial 2014 Bo Huang
Pei Fen Kuan
1
+ Practical model-based dose-finding in phase I clinical trials: Methods based on toxicity 2003 Peter F. Thall
S.-J. Lee
1
+ Bayesian Nonparametric Modeling for Causal Inference 2010 Jennifer Hill
1
+ PDF Chat Bayesian Inference for Causal Effects: The Role of Randomization 1978 Donald B. Rubin
1
+ Summarizing historical information on controls in clinical trials 2010 Beat Neuenschwander
Gorana Capkun-Niggli
Michael Branson
David J. Spiegelhalter
1
+ PDF Chat Bayesian clinical trials in action 2012 J. Jack Lee
Caleb T. Chu
1
+ PDF Chat Clinical trials: More trials, fewer tribulations 2014 Michael Eisenstein
1
+ Data Analysis Using Stein's Estimator and its Generalizations 1975 Bradley Efron
Carl N. Morris
1
+ Practical implementation of a modified continual reassessment method for dose-finding trials 1998 Steven Piantadosi
Joy Fisher
Stuart A. Grossman
1
+ PDF Chat Bayesian Dose Finding in Oncology For Drug Combinations by Copula Regression 2009 Guosheng Yin
Ying Yuan
1